Small Molecule Screening

Accelerate drug discovery with vectors tailored for precise and efficient small molecule screening.

Benefits of Using Viral Vectors
for Small Molecule Screening

Stable Gene Expression

Lentiviruses integrate into the genome, ensuring long-term target or reporter expression.

High Transduction Efficiency

Efficiently delivers genetic material to diverse cell types for consistent results.

Versatility

Easily engineered for specific targets, reporters, or regulatory elements.

Scalability

Supports large-scale production for high-throughput screening.

How Vectors Work

in Small Molecule Screening

Adeno-associated virus (AAV) is a powerful tool in small-molecule screening, particularly in the context of gene expression modulation, disease modeling, and therapeutic target validation since it has the ability to provide long-term transgene expression, low immunogenicity and increased tissue specificity for targeted screening in a wide variety of cell types and tissues.


AAV vectors can be tailored to express fluorescent and bioluminescent reporters as fusion proteins with the gene of interest or in the UTR (untranslated region). The effect of the small-molecule on the transgene will be measured as a function of the reporter expression.

AAV for Gene Therapy & Disease modeling

Key Applications

of Lentivirus in Small Molecule Screening

Stable Target Expression

Enables long-term expression of target genes for consistent screening results.

Reporter Gene  

Introduces reporters like GFP or luciferase to monitor cellular responses to small molecules.

Pathway Analysis

Modulates specific pathways to assess small molecule effects on signaling or gene regulation.

High-Throughput Screening

Scalable production supports large-scale assays for drug discovery.
Gene Therapy Icon

Customizable Vectors

Offers tailored lentiviral and other viral vectors for precise gene overexpression, silencing, and editing in target validation.
Disease Modeling Icon

High-Quality Vectors

Ensures reliability and reproducibility with rigorous quality control on all vector products.
Disease Modeling Icon

Expertise and Support

Provides guidance and expertise to optimize experimental design and target validation processes.
Target Validation Icon

Rapid Turnaround

Offer fast production and delivery times, allowing you to accelerate your clinical trial screening projects and reduce overall timelines.
Small Molecule Screening Icon

Proven Safety

Our AAV vectors are non-pathogenic and trigger minimal immune responses, making them safe for clinical use.

Use Case

AAV-luciferase vectors are used to assess transcriptional activation or repression in response to small-molecule inhibitors.
The AAV vector will deliver a gene to mimic a disease model, hence bypassing the developmental time to produce a transgenic mouse model. The disease is established within a few weeks and is maintained long-term allowing to screen potential drug candidates to reverse or mitigate the disease.